Herb Allergy F1: Allergy with cold-like symptoms, excessive sputum or discharge, water retention, body ache, asthma, whooping cough and bronchitis.
1. Anti histamine: In lab tests on mice, F1 shows a great ability to reduce allergic reaction. At a dosage of 50 mg/Kg, two hours before the injection of EA IgE to create artificial PCA skin allergy reaction, the treated animal only had 1/16, or 6.25 percent prevailing rate, better than the contrast animal. PCA diameter was only 6.2nm vs. 13.5 nm, about 25% of the comparison group. When tested animals were given another shot to create passive allergic shock reaction, histmaine levels in the treated group only rose from 28ng/0.5ml to 46ng/0.5ml while the comparison group rise from 28 to 166ng/0.5ml, another 72% reduction in allergic reaction. There is a very significant difference between the two groups. Nasitis: Two reports on 103 patients treated with F1 for four weeks found 26 were cured (25.24%), 49 significantly improved (44.95%), 18 improved (17.48%) and only 10 did not improve (9.71%).
2. Bronchial asthma: Four reports on 170 adult asthma patients taking F1 for up to four weeks showed 41 were cured (24.11%), 69 significantly improved (40.58%), 38 improved (22.35%) and 22 did not improve (12.94%). Three reports on 154 pediatric asthma patients taking F1 found 72 were cured (46.75%), 28 significantly improved (18.18%), 25 improved (16.23%) and 29 (18.83%) did not improve after treatment. Several other reports showed similar results.
3. Bronchial pneumonia: 152 pediatric bronchial pneumonia patients from 1 to 4 years old were divided into a treatment group (n=102) taking F1 with western medicine and a comparison group (n=50) taking western medicine only. In the treatment group, all were cured in five to eight days, while the comparison group required seven to 16 days for the same results. Another report on 37 pediatric pneumonia patients, age ranging from 3 months to 7 years old, treated with F1 showed 35 were cured and 2 improved in 14 treatment days.
4. Asthma and coughing: 252 chronic coughing or asthma patients took F1 for about a week; 248 were cured and 4 improved. 100 whooping cough patients from 2 to 7 years old took F1 or its modification for about a week and were all cured. Another 102 similar patients reached a 96 percent cure rate.
Toxicity and side effects: There are no known side effects or toxicity of F1. A very safe formula. Patients may experience more sweating for the first couple of days on F1. .
